arrow
L

Luis Barrera

beam therapeutics
H指数:22
被引数:3,317

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Platform solutions for commercial challenges to expanding patient access and making gene editing sustainable

针对商业挑战的平台解决方案,以扩大患者访问范围并使基因编辑可持续发展

2025-07-150
PRE
Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and Danaher

推进基因编辑平台以改善罕见病治疗方案的可行性:2024年由ARM、ISCT和Danaher主办的科学交流会的关键见解

2025-06-240
PREAI
Base-editing corrects metabolic abnormalities in a humanized mouse model for glycogen storage disease type-Ia
2024-11-100
OAAI
Directed evolution of adenine base editors with increased activity and therapeutic application

具有增加的活性和治疗应用的腺嘌呤碱基编辑器的定向进化

2020-04-13340
OAAI
Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10
2019-01-21512
PREAI
Unexpected mutations after CRISPR-Cas9 editing in vivo
2018-03-3022
PREAI